Association between SGLT2 Inhibitors and Risk of Dementia and Parkinson’s Disease: A Meta-Analysis of 12 Randomized Controlled Trials

By sjmartinez • July 9, 2024

Jaiswal V, Mashkoor Y, Raj N, Rajak K, Jaiswal A, Fonarow GC. Association between SGLT2 Inhibitors and Risk of Dementia and Parkinson's Disease: A Meta-Analysis of 12 Randomized Controlled Trials. Am J Med. 2024 Jul 6:S0002-9343(24)00420-0. doi: 10.1016/j.amjmed.2024.06.030. Epub ahead of print. PMID: 38977148.

Tags: Cardiology/Epi, Dementia, diabetes mellitus, heart failure, Parkinson’s disease, Publications, SGLT2I

Related Posts

Tricuspid transcatheter edge-to-edge repair for severe tricuspid regurgitation: 1-year outcomes from the TRILUMINATE randomized cohort

Tang GHL, Hahn RT, Whisenant BK, Hamid N, Naik H, Makkar RR, Tadros P, Price MJ, Singh GD, Fam NP, Kar S, Mehta SR, Bae[...]

Mobile Stroke Unit Management in Patients With Acute Ischemic Stroke Eligible for Intravenous Thrombolysis

Mac Grory B, Sun JL, Alhanti B, Lusk J, Li F, Adeoye O, Furie K, Hasan D, Messe S, Sheth KN, Schwamm LH, Smith EE,[...]

Trends and Disparities in Coronary Artery Disease and Obesity-Related Mortality in the United States From 1999-2022

Ahmed M, Javaid H, Shafiq A, Nadeem ZA, Ahsan A, Nofal A, Ahmed R, Alam M, Fudim M, Fonarow GC, Mamas MA. Trends and Disparities[...]